Common Cold News and Research

RSS

Common HIV drugs linked to reduced Alzheimer's disease risk

Alzheimer's disease (AD) currently afflicts nearly seven million people in the U.S. With this number expected to grow to nearly 13 million by 2050, the lack of meaningful therapies represents a major unmet medical need.

16 Apr 2024

Antibiotics ineffective for cough treatment in lower respiratory tract infections

Use of antibiotics provided no measurable impact on the severity or duration of coughs even if a bacterial infection was present, finds a large, prospective study of people who sought treatment in U.S. primary or urgent care settings for lower-respiratory tract infections.

15 Apr 2024

Study reveals the impact of prompt design on ChatGPT's health advice accuracy

Study by CSIRO and The University of Queensland highlights how the phrasing of prompts influences the accuracy of health information provided by ChatGPT, showing a significant variance in effectiveness based on prompt design.

4 Apr 2024

mRNA vaccines train T cells in waves, study shows

mRNA vaccines developed against the spike glycoprotein of severe acute respiratory syndrome type 2 coronavirus (SARS-CoV-2), displayed remarkable efficiency in combating coronavirus 19 (COVID-19).

9 Mar 2024

Unlocking vitamin B6's role in pancreatic cancer and immune system battle

Vitamin B6 is beneficial in many ways, notably for its role in maintaining a strong immune system. However, when pancreatic cancer develops, its cells also need vitamin B6 to replicate.

23 Feb 2024

HBO's 'The Last of Us' fungal apocalypse, science fiction, not future reality

Researchers in "Emerging Infectious Diseases" debunk the scenario of a global fungal pandemic as depicted in HBO's 'The Last of Us,' citing slow fungal evolution and current pathologies as barriers to such an event.

15 Feb 2024

SARS-CoV-2 fragments found to mimic immune system peptides, fueling inflammation

Study reveals SARS-CoV-2 fragments mimic immune peptides, potentially driving the virus's inflammatory response, offering insights into COVID-19's severe inflammation mechanisms.

5 Feb 2024

"Zombie" viral fragments trigger inflammation to cause serious COVID-19 outcomes

There are many lingering mysteries from the COVID-19 pandemic. For instance, why does SARS-CoV-2, the virus behind the disease, cause severe symptoms in some patients, while many other coronaviruses don't? And what causes strange symptoms to persist even after the infection has been cleared from a person's system?

30 Jan 2024

Prior exposure to common cold coronaviruses can train T cells to fight SARS-CoV-2

Scientists at La Jolla Institute for Immunology (LJI) have found direct evidence that exposure to common cold coronaviruses can train T cells to fight SARS-CoV-2. In fact, prior exposure to a common cold coronavirus appears to partially protect mice from lung damage during a subsequent SARS-CoV-2 infection.

27 Jan 2024

Can vitamin C reduce the severity of the common cold?

The effect of vitamin C supplementation on common cold severity and duration.

13 Dec 2023

New 4-in-1 test can differentiate between swine flu, COVID-19, RSV, and influenza

The first case of a new strain of ‘swine flu’ has been detected in a human in the UK. The last swine flu pandemic killed 457 people in Britain alone. A leading testing expert says this strain looks to be very different but is urging Brits to take precautions.

4 Dec 2023

Human behavior may drive the evolution of new coronavirus strains

Using artificial intelligence technology and mathematical modeling, a research group led by Nagoya University has revealed that human behavior, such as lockdowns and isolation measures, affect the evolution of new strains of COVID-19.

21 Nov 2023

Uniting Against Antimicrobial Resistance: An Interview with the World Health Organization

An interview with Kitty van Weezenbeek, Director of Surveillance, Prevention and Control of AMR for the World Health Organistion (WHO) AMR division.

20 Nov 2023

MHRA extends the license of two cystic fibrosis drugs for children aged two to five years old

The Medicines and Healthcare products Regulatory Agency (MHRA) has today (15 November 2023) extended the licence of the cystic fibrosis medicines Kaftrio (ivacaftor, tezacaftor and elexacaftor) and Kalydeco (ivacaftor) for children aged two to five years old.

20 Nov 2023

Immune imprinting: The crux of waning COVID-19 booster effectiveness against new variants

The study in Nature Microbiology reviews the concept of immune imprinting and its influence on antibody responses to SARS-CoV-2, highlighting challenges for COVID-19 booster vaccination efficacy against emerging variants. Researchers suggest that understanding immune imprinting is crucial for developing vaccines that elicit broad and lasting immune protection.

7 Nov 2023

Children's immune system better prepared to defend against SARS-CoV-2, study finds

Why are severe courses of SARS-CoV-2 infection much less common in children and adolescents than in adults? Scientists at the German Cancer Research Center (Deutsches Krebsforschungszentrum, DKFZ) have now discovered that the immune system in the upper respiratory tract is much more alert and active in children before infection than in adults and is therefore better equipped to fight the virus.

18 Oct 2023

Common Cold News and Research

Common HIV drugs linked to reduced Alzheimer's disease risk

Antibiotics ineffective for cough treatment in lower respiratory tract infections

Study reveals the impact of prompt design on ChatGPT's health advice accuracy

mRNA vaccines train T cells in waves, study shows

Unlocking vitamin B6's role in pancreatic cancer and immune system battle

HBO's 'The Last of Us' fungal apocalypse, science fiction, not future reality

SARS-CoV-2 fragments found to mimic immune system peptides, fueling inflammation

"Zombie" viral fragments trigger inflammation to cause serious COVID-19 outcomes

Prior exposure to common cold coronaviruses can train T cells to fight SARS-CoV-2

Can vitamin C reduce the severity of the common cold?

New 4-in-1 test can differentiate between swine flu, COVID-19, RSV, and influenza

Human behavior may drive the evolution of new coronavirus strains

Uniting Against Antimicrobial Resistance: An Interview with the World Health Organization

MHRA extends the license of two cystic fibrosis drugs for children aged two to five years old

Immune imprinting: The crux of waning COVID-19 booster effectiveness against new variants

Children's immune system better prepared to defend against SARS-CoV-2, study finds

Comparing the lasting effects: post COVID vs. non-COVID acute respiratory infections

Study reveals how a tiny strand of RNA controls T-cell memory to recognize tumors

Oxford University study administers first-ever vaccine against Crimean-Congo hemorrhagic fever

Annual NHS flu vaccination program for children is getting underway

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

From Puberty to Menopause: Clue’s CEO, Audrey Tsang on the Power of Femtech

Latest News